BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 27852668)

  • 21. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
    Gupta BK; Saha AK; Mukherjee S; Saha B
    Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2012 Oct; 10():CD008310. PubMed ID: 23076945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Surfactant Administration Techniques: Will They Change Outcome?
    Barkhuff WD; Soll RF
    Neonatology; 2019; 115(4):411-422. PubMed ID: 30974437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.
    Nayeri FS; Esmaeilnia Shirvani T; Aminnezhad M; Amini E; Dalili H; Moghimpour Bijani F
    Acta Med Iran; 2014; 52(8):596-600. PubMed ID: 25149882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is Less Invasive Surfactant Administration Necessary or "Only" Helpful or Just a Fashion?
    Lista G; Bresesti I; Fabbri L
    Am J Perinatol; 2018 May; 35(6):530-533. PubMed ID: 29694989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies.
    Aguar M; Cernada M; Brugada M; Gimeno A; Gutierrez A; Vento M
    Acta Paediatr; 2014 Jun; 103(6):e229-33. PubMed ID: 24628379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial.
    Pareek P; Deshpande S; Suryawanshi P; Sah LK; Chetan C; Maheshwari R; More K
    J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34595526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.
    Göpel W; Kribs A; Ziegler A; Laux R; Hoehn T; Wieg C; Siegel J; Avenarius S; von der Wense A; Vochem M; Groneck P; Weller U; Möller J; Härtel C; Haller S; Roth B; Herting E;
    Lancet; 2011 Nov; 378(9803):1627-34. PubMed ID: 21963186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive Ventilation With vs Without Early Surfactant to Prevent Chronic Lung Disease in Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Chai-Adisaksopha C; McDonald SD
    JAMA Pediatr; 2015 Aug; 169(8):731-9. PubMed ID: 26053455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Less invasive surfactant administration versus intubation-surfactant-extubation in the treatment of neonatal respiratory distress syndrome: a systematic review and meta-analyses.
    Silveira RC; Panceri C; Munõz NP; Carvalho MB; Fraga AC; Procianoy RS
    J Pediatr (Rio J); 2024; 100(1):8-24. PubMed ID: 37353207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
    Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
    Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surfactant therapy in premature babies: SurE or InSurE.
    Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
    Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery.
    Pinheiro JM; Santana-Rivas Q; Pezzano C
    J Perinatol; 2016 Mar; 36(3):196-201. PubMed ID: 26633145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial.
    Vento G; Pastorino R; Boni L; Cota F; Carnielli V; Cools F; Dani C; Mosca F; Pillow J; Polglase G; Tagliabue P; van Kaam AH; Ventura ML; Tana M; Tirone C; Aurilia C; Lio A; Ricci C; Gambacorta A; Consigli C; D'Onofrio D; Gizzi C; Massenzi L; Cardilli V; Casati A; Bottino R; Pontiggia F; Ciarmoli E; Martinelli S; Ilardi L; Colnaghi M; Matassa PG; Vendettuoli V; Villani P; Fusco F; Gazzolo D; Ricotti A; Ferrero F; Stasi I; Magaldi R; Maffei G; Presta G; Perniola R; Messina F; Montesano G; Poggi C; Giordano L; Roma E; Grassia C; Ausanio G; Sandri F; Mescoli G; Giura F; Garani G; Solinas A; Lucente M; Nigro G; Del Vecchio A; Petrillo F; Orfeo L; Grappone L; Quartulli L; Scorrano A; Messner H; Staffler A; Gargano G; Balestri E; Nobile S; Cacace C; Meli V; Dallaglio S; Pasqua B; Mattia L; Gitto E; Vitaliti M; Re MP; Vedovato S; Grison A; Berardi A; Torcetta F; Guidotti I; di Fabio S; Maranella E; Mondello I; Visentin S; Tormena F
    Trials; 2016 Aug; 17():414. PubMed ID: 27538798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center.
    Bao Y; Zhang G; Wu M; Ma L; Zhu J
    BMC Pediatr; 2015 Mar; 15():21. PubMed ID: 25885964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
    Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
    Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.
    Ines F; Hutson S; Coughlin K; Hopper A; Banerji A; Uy C; Finer N; Rich W; Morales A; Steen J; Katheria AC
    BMJ Open; 2021 Jan; 11(1):e038343. PubMed ID: 33483435
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.